Lv1
30 积分 2023-04-20 加入
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies
2个月前
已完结
Update on Mpox Management: Epidemiology, Vaccines and Therapeutics, and Regulatory Changes
3个月前
已完结
Mito-FLAG as Salvage Therapy for Relapsed and Refractory Acute Myeloid Leukemia
4个月前
已完结
A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group
4个月前
已完结
Comparison of cladribine- and fludarabine-based induction chemotherapy in relapsed or refractory acute myeloid leukaemia
4个月前
已完结
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial
5个月前
已完结
Venetoclax plus ‘2 + 5’ modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single‐centre retrospective analysis
6个月前
已完结
Lymphoblastic lymphoma
6个月前
已完结
皖公网安备34019202002308
